Vanderbilt-Ingram Cancer Center

Southern Environmental Health Study recruiting participants

People who sign up can help researchers assess whether environmental factors may be the culprits behind the region’s higher cancer burden.

Tae Kon Kim receives V Foundation grant for MDS drug research

Kim and colleagues will study whether this protein hinders the ability of the immune system to fight MDS and whether it can be blocked to treat MDS.

Chic Awearness surpasses $1 million for ovarian cancer research and patient support

Founded by Marci Houff, the event supports ovarian cancer research at Vanderbilt-Ingram Cancer Center and patient support initiatives.

By Tom Wilemon and Erin O. Smith

Michael Gibson votes with FDA panel to limit immunotherapy indication

The panel determined that allowing the wider indication would put patients at risk for adverse reactions from the two immunotherapies but without the added benefit in survival.

Cathy Eng named Vanderbilt-Ingram Cancer Center associate director of Strategic Relations and Research Partnerships

Her new responsibilities will include promoting clinical research by developing new strategic partnerships with pharmaceutical and biotech companies.

New Video: Study shows cancer vaccine blocks tumor progression at early lesion stage

Senior author Mary Philip, MD, PhD, associate director of the Vanderbilt Institute for Infection, Immunology and Inflammation, talks about her Journal for ImmunoTherapy of Cancer study.
The findings support further vaccine investigation to make long-term, progression-free survival a reality for more cancer patients.